Friday, June 12, 2026
spot_img
HomeIndustries

Industries

IDEAYA Announces Selection of IDE397 Phase 2 Monotherapy Expansion Dose For Global Enrollment Targeting High Priority MTAP-Deletion Solid Tumor Types

IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced selection of a monotherapy expansion dose...

HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Opportunities in Parkinson’s Disease

HanAll Biopharma and Daewoong Pharmaceutical announced the expansion of their open collaboration strategy by investing in Vincere Biosciences, a Cambridge, MA-based company developing therapeutics...

Corteva Agriscience Harnesses Nature to Unlock Plant Disease Resistance

Corteva Agriscience announced publication of research confirming the natural movement of disease resistance genes within a corn plant's genome. The research has implications for...

J.P. Morgan Launches Sustainable Investment Data Solutions for Institutional Investors

J.P. Morgan Securities Services announced today the launch of its Sustainable Investment Data Solutions for institutional investors, available through Fusion by J.P. Morgan. The solution will...

3D Cloud by Marxent Announces Early Access Program for 3D Cloud Room Scanner

3D Cloud by Marxent, the leader in 3D kitchen design and furniture planning, is excited to announce an early access program for the highly...

Hot Topics

spot_img